Gene · 3909
NIH grants936
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 936
Download this page as JSON| Grant | Title | LAMA3 papers | Newest fiscal year |
|---|---|---|---|
| P60AA009803 | LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center (CARC) | 1 | 2025 |
| R01AG034924 | mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease | 1 | 2025 |
| R01AI109023 | Defining P. falciparum resistance to artemisinin-based combination therapies | 1 | 2025 |
| R01AI124214 | Role of Type 2 Immunity in Innate Protection from C. difficile | 1 | 2025 |
| R01AI124678 | Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum | 1 | 2025 |
| R01AI152477 | Mechanisms of Fecal Microbiota Transplant Protection from Recurrent C. difficile | 1 | 2025 |
| R01AR043799 | Mechanisms of Epidermal Homeostasis and Early Neoplasia | 1 | 2025 |
| R01AR046786 | Stromal Regulation of Basal Cell Carcinoma Formation | 1 | 2025 |
| R01AR063070 | Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa | 1 | 2025 |
| R01AR071435 | Transcriptional regulation of skin stem cells and their niche | 1 | 2025 |
| R01AR077563 | Molecular Determinants of Pigmentation (MDoP) | 1 | 2025 |
| R01AR077591 | Intrinsic and extrinsic spindle orientation mechanisms in mammalian epidermis | 1 | 2025 |
| R01CA142779 | PD-1/PD-L1 modulation in cancer therapy | 1 | 2025 |
| R01CA163336 | Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data | 1 | 2025 |
| R01CA253976 | DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy | 1 | 2025 |
| R01CA254060 | Leader cell development and function in Breast Tumor Collective Migration | 1 | 2025 |
| R01DC018577 | Bioprintable composite materials and microfluidic tools for vocal fold restoration and repair | 1 | 2025 |
| R01DK075787 | Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum | 1 | 2025 |
| R01EB024989 | Detection of Emergent Mechanical Properties of Biologically Complex Cellular States | 1 | 2025 |
| R01ES004738 | Activated Macrophages and Ozone Toxicity | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3909/grants?page=6